HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,815 | -13.6% | 10,500 | -2.7% | 0.00% | 0.0% |
| Q2 2023 | $12,517 | -23.2% | 10,790 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $16,293 | -37.9% | 10,790 | +2.8% | 0.00% | -50.0% |
| Q4 2022 | $26,250 | -89.9% | 10,500 | -0.8% | 0.00% | -94.1% |
| Q1 2019 | $260,000 | -5.8% | 10,585 | -0.0% | 0.03% | -24.4% |
| Q4 2018 | $276,000 | -15.6% | 10,590 | +0.9% | 0.04% | -22.4% |
| Q3 2018 | $327,000 | -20.2% | 10,500 | 0.0% | 0.06% | -23.7% |
| Q2 2018 | $410,000 | +41.4% | 10,500 | 0.0% | 0.08% | +35.7% |
| Q1 2018 | $290,000 | +52.6% | 10,500 | 0.0% | 0.06% | +55.6% |
| Q4 2017 | $190,000 | +5.6% | 10,500 | 0.0% | 0.04% | -5.3% |
| Q3 2017 | $180,000 | +24.1% | 10,500 | 0.0% | 0.04% | +15.2% |
| Q2 2017 | $145,000 | -9.9% | 10,500 | 0.0% | 0.03% | -10.8% |
| Q1 2017 | $161,000 | – | 10,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 21,288 | $250,000 | 19.87% |
| TANG CAPITAL MANAGEMENT LLC | 2,896,904 | $34,010,000 | 4.78% |
| PFM Health Sciences, LP | 2,481,917 | $29,138,000 | 2.39% |
| Iron Triangle Partners LP | 500,000 | $5,870,000 | 2.27% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 777,599 | $9,129,000 | 1.72% |
| Pekin Hardy Strauss, Inc. | 588,732 | $6,912,000 | 1.55% |
| First Light Asset Management, LLC | 691,400 | $8,117,000 | 1.39% |
| Congress Park Capital LLC | 111,045 | $1,304,000 | 1.18% |
| Mesirow Financial Investment Management, Inc. | 15,135 | $178,000 | 1.12% |
| Elk Creek Partners, LLC | 509,174 | $5,978,000 | 1.03% |